Investigation of pH-sensitive galactopyranoside glycol hydrogels as effective vehicles for oral drug delivery

被引:15
|
作者
Zakhireh, Solmaz [1 ]
Mahkam, Mehrdad [2 ]
Yadollahi, Mehdi [3 ]
Jafarirad, Saeed [4 ]
机构
[1] Islamic Azad Univ, Ilkhchi Branch, Young Researchers & Elite Club, Ilkhchi, Iran
[2] Azarbaijan Shahid Madani Univ, Dept Chem, Tabriz, Iran
[3] Univ Tabriz, Dept Chem, Tabriz, Iran
[4] Univ Tabriz, Res Inst Fundamental Sci RIFS, Tabriz, Iran
关键词
Glycol hydrogel; Oral drug delivery; Methacrylic acid (MAA); Allyl alpha-D-galactopyranoside; COLON-SPECIFIC DRUG; 5-AMINOSALICYLIC ACID; CONTROLLED-RELEASE; POLYMERS; CHITOSAN; SYSTEM;
D O I
10.1007/s10965-014-0398-3
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
High-loading-capacity pH-sensitive glycol hydrogels were developed using allyl alpha-D-galactopyranoside as a biodegradable and biocompatible carbohydrate. These new pH-sensitive glycol polymers were obtained through the free-radical polymerization of methacrylic acid and allyl alpha-D-galactopyranoside using 1,6-hexanediol diacrylate and 1,6-hexanediol propoxylate diacrylate as crosslinker. The novel sugar-bearing galactopyranoside-based hydrogels were analyzed to test their hydrolytic behavior in vitro, considering their potential application as drug delivery systems. Equilibrium swelling studies were carried out in enzyme-free simulated gastric and intestinal fluids (SGF and SIF; pH 8 and pH 1, respectively). A model drug, olsalazine (an azo derivative of 5-aminosalicylic acid), was entrapped in these gels, and their in vitro release profiles were established separately in SGF and SIF at 37 A degrees C. The swelling and drug release profiles revealed that the amount of drug released and swelling of the hydrogels depended on the methacrylic acid content and the crosslinker type and content.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] pH-Sensitive Polyketal Nanoparticles for Drug Delivery
    Wang, Yang
    Chang, Baisong
    Yang, Wuli
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2012, 12 (11) : 8266 - 8275
  • [32] Acetals as pH-sensitive linkages for drug delivery
    Gillies, ER
    Goodwin, AP
    Fréchet, JMJ
    BIOCONJUGATE CHEMISTRY, 2004, 15 (06) : 1254 - 1263
  • [33] Synthesis and Characterization of Novel pH-sensitive Nano Composites for Oral Drug Delivery
    Mahkam, Mehrdad
    CURRENT NANOSCIENCE, 2012, 8 (05) : 744 - 748
  • [34] Tailored Polymersomes for Enhanced Oral Drug Delivery: pH-Sensitive Systems for Intestinal Delivery of Immunosuppressants
    Tollemeto, Matteo
    Ursulska, Sintija
    Welzen, Pascal L. W.
    Thamdrup, Lasse H. E.
    Permlid, Atena Malakpour
    Li, Yudong
    Soufi, Gohar
    Padial, Tania Patino
    Christensen, Jorn B.
    Nielsen, Line Hagner
    van Hest, Jan
    Boisen, Anja
    SMALL, 2024, 20 (43)
  • [35] Salicylic acid-based, pH-sensitive hydrogels as potential oral insulin delivery system
    Demirdirek, Bahar
    Uhrich, Kathryn
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [36] Salicylic acid-based pH-sensitive hydrogels as potential oral insulin delivery systems
    Demirdirek, Bahar
    Uhrich, Kathryn E.
    JOURNAL OF DRUG TARGETING, 2015, 23 (7-8) : 716 - 724
  • [37] pH-sensitive and bioadhesive poly(β-amino ester)-poly(ethylene glycol)-poly(β-amino ester) triblock copolymer hydrogels with potential for drug delivery in oral mucosal surfaces
    Nguyen, Minh Khanh
    Huynh, Cong Truc
    Lee, Doo Sung
    POLYMER, 2009, 50 (22) : 5205 - 5210
  • [38] Salecan-Based pH-Sensitive Hydrogels for Insulin Delivery
    Qi, Xiaoliang
    Wei, Wei
    Li, Junjian
    Zuo, Gancheng
    Pan, Xihao
    Su, Ting
    Zhang, Jianfa
    Dong, Wei
    MOLECULAR PHARMACEUTICS, 2017, 14 (02) : 431 - 440
  • [39] Swelling of pH-sensitive hydrogels
    Drozdov, A. D.
    Christiansen, J. deClaville
    PHYSICAL REVIEW E, 2015, 91 (02):
  • [40] Enzymatically degradable and pH-sensitive hydrogels for colon-targeted oral drug delivery. I. Synthesis and characterization
    Bajpai, S.K.
    Saxena, Sutanjay
    1600, John Wiley and Sons Inc. (92):